G1 Therapeutics Inc (GTHX)
4.58
+0.14
(+3.15%)
USD |
NASDAQ |
May 03, 12:16
G1 Therapeutics Cash from Investing (Quarterly): -7.647M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -7.647M |
September 30, 2023 | 7.201M |
June 30, 2023 | 0.346M |
March 31, 2023 | 2.91M |
December 31, 2022 | -20.36M |
September 30, 2022 | -29.66M |
June 30, 2022 | -0.506M |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.152M |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
Date | Value |
---|---|
December 31, 2019 | -1.10M |
September 30, 2019 | -1.224M |
June 30, 2019 | -0.176M |
March 31, 2019 | -0.216M |
December 31, 2018 | -0.111M |
September 30, 2018 | -0.414M |
June 30, 2018 | -0.113M |
March 31, 2018 | -0.071M |
December 31, 2017 | -0.024M |
September 30, 2017 | -0.236M |
June 30, 2017 | -0.021M |
March 31, 2017 | -0.013M |
December 31, 2016 | -0.041M |
September 30, 2016 | -0.124M |
June 30, 2016 | -0.0287M |
March 31, 2016 | -0.0563M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-29.66M
Minimum
Sep 2022
7.201M
Maximum
Sep 2023
-2.635M
Average
--
Median
Mar 2020
Cash from Investing (Quarterly) Benchmarks
Amicus Therapeutics Inc | -23.96M |
Geron Corp | 47.57M |
Palatin Technologies Inc | 9.462M |
Oragenics Inc | -1.00M |
TG Therapeutics Inc | -44.76M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -12.79M |
Cash from Financing (Quarterly) | 0.034M |
Free Cash Flow | -38.34M |
Free Cash Flow Per Share (Quarterly) | -0.2468 |
Free Cash Flow to Equity (Quarterly) | -13.10M |
Free Cash Flow to Firm (Quarterly) | -11.05M |
Free Cash Flow Yield | -15.48% |